Kerrie D. Symmonds
Ask VT AI
View News Summary
- Russia tests nuclear-powered cruise missile, raising concerns over technical challenges and strategic implications.
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a damning report.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Russia tests nuclear-powered cruise missile, raising concerns over technical challenges and strategic implications.
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a damning report.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Kerrie D. Symmonds
News from Kerrie D. Symmonds
